Probiotic Ingredients Market Report

Global Probiotic Ingredients Market Size

The Probiotic Ingredients market size was valued at USD 61.01 billion in 2024, and the market size is expected to reach USD 120.55 billion by 2033 from USD 65.81 billion in 2025. The market's promising CAGR for the predicted period is 7.86%.

Probiotic Ingredients are live microorganisms that, when consumed in adequate amounts, confer health benefits on the host. These beneficial bacteria, primarily strains of Lactobacillus , Bifidobacterium, and Saccharomyces, are widely used in food, dietary supplements, infant nutrition, animal feed, and pharmaceuticals. The market is driven by increasing awareness of gut health, the role of microbiota in immunity, and the preventive healthcare approach adopted by consumers across age groups.

Like, digestive disorders affect over 40% of the global population, . This has heightened interest in functional foods and beverages containing probiotic ingredients.

In Asia, particularly in countries like Japan and South Korea, long-standing traditions of fermented food consumption have laid a strong foundation for probiotic ingredient integration into modern diets.

With scientific research increasingly validating the benefits of probiotics—from mental wellness to metabolic health—the demand for standardized, strain-specific, and clinically tested probiotic ingredients continues to rise across industries globally.

MARKET DRIVERS

Rising Prevalence of Digestive and Immune Disorders

The escalating prevalence of digestive and immune-related conditions worldwide is one of the primary drivers of the Probiotic Ingredients Market. These conditions have intensified the need for alternative, non-invasive interventions, prompting increased adoption of probiotic ingredients in both clinical and consumer settings.

In the United States, the National Institutes of Health (NIH) reports that IBS alone affects approximately 10–15% of the population, with many turning to probiotic supplements or fortified foods to manage symptoms. Clinical studies indicate that specific probiotic strains, such as Lactobacillus rhamnosus and Bifidobacterium lactis , have demonstrated efficacy in reducing bloating, gas, and irregular bowel movements.

Similarly, in Europe, the European Society for Primary Care Gastroenterology (ESPCG) shows that general practitioners increasingly recommend probiotics as part of treatment regimens for patients suffering from dysbiosis and related complications.

Expansion of Probiotic Applications Across Multiple Industries

The broadening application of probiotics beyond traditional dietary supplements and dairy products into diverse sectors such as pharmaceuticals, infant nutrition, cosmetics, and animal feed is another significant driver of the Probiotic Ingredients Market. According to the Food and Agriculture Organization (FAO), the use of probiotics in livestock farming has grown substantially due to regulatory restrictions on antibiotic growth promoters, especially in the European Union and North America.

In the infant nutrition segment, the World Health Organization (WHO) emphasizes the importance of early microbial colonization in newborns, leading to increased incorporation of probiotics in infant formula and baby food. Moreover, the cosmetic industry has embraced probiotic-based skincare products aimed at enhancing skin barrier function and managing conditions like acne and rosacea. This diversification of probiotic applications significantly widens the market’s scope and accelerates its growth trajectory.

MARKET RESTRAINTS

Lack of Standardization and Regulatory Ambiguity

The lack of uniform standards regarding strain identification, dosage requirements, and health claims is a key restraint in the Probiotic Ingredients Market. Unlike pharmaceuticals, which undergo rigorous approval processes, probiotic ingredients often fall under food or supplement regulations, which vary widely across regions. According to the International Scientific Association for Probiotics and Prebiotics (ISAPP), inconsistencies in labeling, strain specificity, and clinical validation pose challenges for both manufacturers and consumers.

In India, the Food Safety and Standards Authority of India (FSSAI) does not yet have a comprehensive regulatory framework specifically for probiotic ingredients, leading to discrepancies in product quality and efficacy claims. Similarly, in China, while the National Health Commission has issued guidelines for probiotic use in infant formula, broader food applications remain loosely regulated, affecting consumer trust. Besides, the absence of a unified global certification system hampers international trade and export opportunities for probiotic ingredient suppliers. This regulatory fragmentation creates uncertainty, limiting market expansion and hindering investment in innovation.

Limited Consumer Awareness and Misconceptions

Misconceptions about the effectiveness and necessity of probiotic ingredients persist, particularly in emerging markets. Like, awareness levels regarding the benefits of probiotics remain low in several Southeast Asian and African countries, where traditional medicine and home remedies still dominate healthcare choices.

Misinformation spread through unverified online sources further exacerbates confusion, with some consumers believing that all fermented foods contain effective probiotic strains or that higher colony-forming units (CFUs) always equate to better results.

Moreover, in regions where access to healthcare professionals is limited, self-medication with probiotic supplements without medical guidance is common, leading to inconsistent outcomes. This trend can result in misuse and diminished consumer confidence if expectations are not met.

MARKET OPPORTUNITIES

Integration of Probiotics in Functional Foods and Beverages

The growing incorporation of probiotics into functional foods and beverages is a potential opportunity in the Probiotic Ingredients Market. Consumers are increasingly seeking out everyday products that offer added health benefits, including digestive support, immunity enhancement, and overall wellness.

In Japan, companies have successfully expanded their probiotic beverage portfolios to include options tailored for senior citizens, children, and individuals with specific dietary needs. These products are backed by extensive research and are often prescribed alongside medications to improve gut flora balance.

In North America, plant-based and dairy-free alternatives enriched with probiotics are witnessing high demand. Brands have introduced probiotic-infused kombucha, coconut water, and almond milk drinks that cater to vegan and health-conscious consumers.

This trend is now spreading to emerging markets, where local producers are developing affordable probiotic yogurts and fermented juices. Such innovations provide new revenue streams for ingredient suppliers and reinforce the expanding role of probiotics in mainstream nutrition.

Advancements in Personalized Probiotics and Microbiome Research

Rapid advancements in microbiome science are opening new avenues for personalized probiotic formulations tailored to individual health profiles. According to the Human Microbiome Project, funded by the U.S. National Institutes of Health (NIH), each person’s gut microbiota is unique, influencing everything from metabolism to mood regulation. This insight has led to the development of customized probiotic blends based on genetic markers, lifestyle, and dietary habits.

Companies like Seed Health and Viome are pioneering direct-to-consumer microbiome testing kits that analyze gut composition and recommend specific probiotic strains for optimal health outcomes. These services have gained popularity among health-conscious individuals and medical professionals alike, signaling a shift from one-size-fits-all solutions to precision nutrition.

In academic and clinical settings, universities and research institutions are conducting trials to determine how specific probiotic strains can address conditions such as obesity, depression, and autoimmune diseases. For example, a 2023 study by Harvard T.H. Chan School of Public Health found that certain Lactobacillus strains could influence serotonin production, offering potential applications in mental health management.

MARKET CHALLENGES

Strain-Specific Efficacy and Clinical Validation Requirements

The increasing demand for strain-specific efficacy and clinical validation is one of the most pressing challenges facing the Probiotic Ingredients Market. Unlike generic nutritional supplements, probiotics must demonstrate measurable health benefits tied to particular bacterial strains, dosages, and delivery mechanisms. According to the International Scientific Association for Probiotics and Prebiotics (ISAPP), only a small percentage of commercially available probiotic products have undergone rigorous clinical testing to substantiate their claimed benefits.

Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) require substantial scientific evidence before approving health claims for probiotic ingredients. This has created a bottleneck for smaller manufacturers who may lack the resources to conduct large-scale clinical trials, limiting their ability to compete with established players.

Furthermore, the variability in human response to different probiotic strains complicates universal recommendations. Identical probiotic strains can yield varying effects depending on an individual's baseline microbiota composition. This complexity necessitates personalized approaches, adding another layer of difficulty in achieving broad market acceptance.

Stability and Shelf-Life Limitations of Live Cultures

Maintaining the viability of live probiotic cultures throughout manufacturing, distribution, and storage presents a major technical challenge for the industry. Probiotic ingredients are highly sensitive to environmental factors such as temperature, moisture, and oxygen exposure, which can compromise their potency and effectiveness.

In developing countries, where cold chain infrastructure is often inadequate, maintaining product integrity becomes even more difficult. A report by the United Nations Industrial Development Organization (UNIDO) noted that improper storage conditions contribute to high spoilage rates of probiotic-containing foods, particularly in tropical climates where humidity and heat accelerate bacterial degradation.

To combat this issue, manufacturers are investing in microencapsulation technologies that shield probiotic cells from harsh conditions until they reach the gastrointestinal tract. However, these methods add to production costs and require specialized equipment, making them less accessible to small-scale producers.

Additionally, consumer awareness regarding expiration dates and proper storage practices remains limited, leading to reduced perceived value of probiotic products.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Form Insights

The dry/powder form segment led the probiotic ingredients market, accounting for approximately 58% of total value in 2024. The dominance of this segment is primarily attributed to the widespread use of powdered probiotics in dietary supplements, infant formulas, and functional foods, where stability, longer shelf life, and ease of formulation are critical. Generally, dry probiotic powders offer superior microbial viability during storage compared to liquid forms, especially under fluctuating temperature conditions. This makes them ideal for incorporation into a variety of food matrices, including baked goods, cereals, and protein shakes.

Additionally, the growing popularity of probiotic-enriched powdered beverages and supplements among health-conscious consumers has further reinforced this segment’s position. Manufacturers also favor dry forms due to cost-effective production and packaging, which supports large-scale manufacturing and global distribution. These factors collectively contribute to the sustained leadership of the dry/powder segment in the probiotic ingredients market.

The liquid form segment is the fastest-growing in the probiotic ingredients market, projected to expand at a CAGR of 9.3% from 2025 to 2033. The growth of this segment is largely propelled by the increasing incorporation of probiotics into ready-to-drink beverages, dairy products, and fermented drinks, which are gaining traction among consumers seeking functional nutrition. In Japan, for instance, probiotic beverages such as Yakult and Calpis have become household staples, with new entrants introducing plant-based and low-sugar variants to cater to evolving dietary preferences.

Moreover, the convenience of direct consumption and faster absorption of live cultures in liquid form make it a preferred choice for individuals with digestive sensitivities. Also, regular consumption of probiotic drinks has been linked to improved gut health among the aging population. Innovations in stabilization technologies, such as microencapsulation and cold-chain logistics, have also enhanced the viability of liquid probiotics, reducing spoilage and ensuring product efficacy. These developments are enabling manufacturers to expand their product portfolios and meet rising consumer demand for on-the-go health solutions.

By Ingredient Insights

The bacteria-based probiotic ingredients segment remained prominent category in the market, estimated at 67% in 2024. The popularity of this segment is primarily due to the widespread use of bacterial strains such as Lactobacillus, Bifidobacterium, and Streptococcus in dietary supplements, functional foods, and animal feed.

According to the International Scientific Association for Probiotics and Prebiotics (ISAPP), bacterial probiotics have been extensively studied and are associated with a wide range of health benefits, including improved digestion, enhanced immunity, and better metabolic health.

Moreover, bacterial probiotics are the most commonly used in fermented dairy products such as yogurt and kefir, which remain a major application area globally. In Europe, the European Food Safety Authority (EFSA) has approved several bacterial strains for use in food products, further boosting their adoption. Manufacturers also prefer bacterial strains for their compatibility with existing food processing techniques and ability to survive the harsh conditions of the gastrointestinal tract. These factors collectively contribute to the continued dominance of the bacteria-based probiotic ingredients segment in the global market.

The spore-forming probiotics segment is the fastest-growing in the market, with a projected CAGR of 10.5% from 2025 to 2033. The progress of this segment is mainly fueled by the increasing recognition of the stability and resilience of spore-forming bacteria such as Bacillus coagulans, Bacillus subtilis, and Clostridium butyricum. According to a 2023 review published by the National Institutes of Health (NIH), spore-forming probiotics have a higher survival rate in the gastrointestinal tract due to their ability to form protective endospores, making them more effective in delivering health benefits compared to traditional bacterial strains.

In the pharmaceutical and nutraceutical sectors, spore-based probiotics are gaining traction for their potential to modulate gut microbiota and treat conditions such as inflammatory bowel disease (IBD) and Clostridioides difficile infection. Also, clinical trials have shown that Bacillus coagulans can significantly reduce symptoms of bloating and abdominal discomfort in patients with IBS.

Additionally, spore-forming probiotics are increasingly being used in animal feed to enhance livestock health and reduce reliance on antibiotics, in line with regulatory restrictions in the European Union and North America. These applications are driving rapid adoption and innovation in this segment, positioning spore-forming probiotics as a key growth driver in the global market.

By Application Insights

The capsules segment was the dominant application in the probiotic ingredients market by holding 34.5% of total share in 2024. The dominance of this segment is primarily due to the high consumer preference for capsule-based probiotic supplements, which offer precise dosing, ease of ingestion, and effective protection of live cultures during digestion. According to the Council for Responsible Nutrition (CRN), over 60% of U.S. adults take dietary supplements, with capsules being the most commonly preferred dosage form for probiotics due to their stability and ease of formulation with multiple bacterial strains.

Additionally, manufacturers favor capsules for their compatibility with a wide range of probiotic strains and the ability to incorporate enteric coatings that enhance gastric resistance. The growing demand for multi-strain probiotic formulations, which are often encapsulated to maintain strain viability and efficacy, has further reinforced this segment’s lead position.

The chewable and gummies segment is the fastest-growing application in the probiotic ingredients market, projected to grow at a CAGR of 11.2% in the coming years. The rapid growth of this segment is largely driven by shifting consumer preferences toward convenient, palatable, and child-friendly dosage forms, particularly in the dietary supplements and functional food sectors. In the United States, probiotic gummies have become a preferred choice for Millennials and Gen Z consumers who prioritize taste and ease of consumption over conventional supplement formats. Companies like Garden of Life, Olly, and SmartyPants have launched gummy probiotics with claims of digestive and immune support, contributing to increased market penetration.

Moreover, advancements in formulation technology have enabled manufacturers to maintain probiotic viability in chewable formats, overcoming previous challenges related to moisture sensitivity and bacterial degradation. These developments are fueling innovation and attracting investment from both established and emerging players in the market.

By End User Insights

The human probiotics segment led the global probiotic ingredients market by capturing a 65.3% of total value in 2024. The dominance of this segment is primarily driven by the rising awareness of gut health, the growing prevalence of digestive and immune-related disorders, and the increasing incorporation of probiotics into dietary supplements, functional foods, and beverages. In the United States, probiotic supplement sales have grown by double digits annually, with an increasing number of healthcare professionals recommending them for gut health management. Additionally, the integration of probiotics into mainstream food and beverage products—such as yogurts, smoothies, and plant-based drinks—has expanded their reach to a broader consumer base.

The growing body of scientific research validating the benefits of probiotics for conditions like lactose intolerance, allergies, and even mental health has further reinforced consumer confidence. As awareness continues to rise and regulatory frameworks evolve, the human probiotics segment is expected to maintain its leadership in the global market.

The animal probiotics segment is the fastest-growing in the market, projected to expand at a CAGR of 9.8% in the future. This growth is primarily driven by the increasing use of probiotics in livestock farming to enhance animal health, improve feed efficiency, and reduce reliance on antibiotic growth promoters. According to the Food and Agriculture Organization (FAO), the global livestock industry is under pressure to adopt sustainable and antibiotic-free practices, particularly in response to regulatory restrictions in the European Union and growing consumer demand for clean-label meat and dairy products.

Also, in China, the Ministry of Agriculture and Rural Affairs has encouraged the use of probiotics as an alternative to antibiotics in livestock feed, aligning with national food safety and sustainability goals. Additionally, the companion animal market is expanding, with pet owners increasingly seeking probiotic supplements for dogs and cats to support digestive and immune health. These factors collectively contribute to the rapid growth of the animal probiotics segment in the global market.

REGIONAL ANALYSIS

North America

North America secured the largest regional share in the probiotic ingredients market and accounted for a 32.5% of total revenue in 2024. The region’s position is primarily driven by high consumer awareness, well-established healthcare infrastructure, and a strong presence of key market players. The U.S. Food and Drug Administration (FDA) has also played a role in shaping the market by setting guidelines for probiotic claims and encouraging scientific validation of health benefits.

Moreover, the proliferation of functional foods and beverages containing probiotic ingredients has contributed to market expansion. Brands such as General Mills, Danone, and Nestlé have introduced probiotic-enriched yogurts, smoothies, and plant-based alternatives that appeal to health-conscious consumers.

The region also benefits from a robust research ecosystem, with universities and research institutions conducting clinical trials to explore the therapeutic potential of probiotics in areas such as mental health, metabolic disorders, and immune modulation. These factors collectively reinforce North America’s dominant position in the global market.

Europe

Europe accounts for a significant portion of the global probiotic ingredients market, supported by stringent regulatory frameworks, a mature nutraceutical industry, and high consumer demand for clean-label products. The European Food Safety Authority (EFSA) has played a pivotal role in ensuring product quality and efficacy by evaluating health claims associated with probiotic ingredients.

Also, the dietary supplements business in Europe has been growing steadily, with probiotics forming a significant segment. Countries such as Germany, France, and the UK have a strong tradition of fermented food consumption, which has facilitated the acceptance of probiotic-enriched products.

In addition, the European Commission has implemented policies to reduce antibiotic use in livestock, promoting the adoption of probiotics in animal feed. This shift aligns with the region’s broader sustainability goals and consumer preference for antibiotic-free food products.

The growing interest in personalized nutrition and microbiome-based therapies is also driving research and development in the probiotic sector. With a combination of regulatory support, scientific innovation, and consumer trust, Europe remains a key growth hub in the global market.

Asia Pacific

Asia Pacific is rapidly expanding in the global probiotic ingredients market, with strong growth potential driven by traditional consumption of fermented foods, rising disposable incomes, and increasing awareness of gut health benefits. Countries such as Japan, South Korea, and India have long-standing dietary habits that include probiotic-rich foods like miso, kimchi, and curd-based dishes.

Also, probiotic consumption is particularly high among the elderly population, with products such as Yakult and probiotic dairy drinks being widely consumed for digestive wellness. In India, the government’s promotion of millet-based and fermented foods under the “Eat Right India” initiative has further encouraged probiotic adoption.

The region is also witnessing a surge in probiotic-infused beverages, supplements, and infant formulas. Companies like Yakult, Morinaga, and Amul have expanded their product lines to meet growing demand, while startups are introducing plant-based and functional probiotic options tailored to local tastes.

Latin America

Latin America is characterized by growing health awareness, increasing prevalence of digestive disorders, and expanding dairy and functional food industries. Countries such as Brazil and Mexico are leading the regional market due to rising consumer interest in natural and preventive healthcare solutions.

Like, digestive diseases are a growing public health concern in Brazil, prompting increased demand for probiotic-enriched foods and supplements. The Brazilian Association of Probiotics and Prebiotics (ABRAPE) has been actively promoting research and education on probiotic benefits, enhancing consumer trust and market expansion.

In Mexico, the dairy sector has embraced probiotic fortification, with companies like Grupo Lala and Danone introducing probiotic yogurts and fermented milk products. These products are increasingly being marketed for digestive health, weight management, and immune support.

Furthermore, the region’s growing middle class and increasing disposable incomes are enabling wider access to premium probiotic products.

Middle East and Africa

The Middle East and Africa region is spearheaded by the global probiotic ingredients market, with growth driven by increasing health consciousness, urbanization, and the rising prevalence of lifestyle-related diseases. While the market is still in its early stages compared to other regions, there is growing interest in probiotic-enriched dairy products and supplements.

Digestive disorders and gut-related conditions are becoming more prevalent in Gulf Cooperation Council (GCC) countries, prompting healthcare professionals to recommend probiotic-based interventions. In Saudi Arabia, for instance, the Ministry of Health has included probiotics in dietary guidelines for managing gastrointestinal health.

In Africa, particularly in South Africa and Egypt, probiotic consumption is gradually increasing due to rising awareness and the expansion of multinational dairy and nutrition brands. Companies such as Nestlé and Danone have introduced probiotic yogurts in these markets, targeting urban consumers seeking functional nutrition.

Despite challenges such as limited regulatory frameworks and lower consumer awareness, the Middle East and Africa region presents significant growth opportunities for probiotic ingredient suppliers, particularly in the food and infant nutrition sectors.

KEY MARKET PLAYERS AND COMPETITIVE LANDSCAPE

Key market players of global probiotic ingredients are Kerry Inc, DSM, Associated British Foods plc, Lallemand Inc

The competition in the probiotic ingredients market is highly fragmented, with a mix of large multinational corporations and emerging regional players vying for market share. Established firms such as Chr. Hansen, Dupont, and Lallemand maintain dominance due to their strong R&D capabilities, global supply chains, and long-standing relationships with food and pharmaceutical companies. However, increasing demand for personalized nutrition and microbiome-based therapies is encouraging smaller biotech firms and startups to enter the space with innovative, niche probiotic formulations.

Product differentiation remains a key battleground, as only scientifically validated and strain-specific probiotics can gain traction among health-conscious consumers and medical professionals. Regulatory scrutiny around health claims and labeling further intensifies competition, particularly in North America and Europe where compliance requirements are strict.

Additionally, vertical integration strategies—ranging from ingredient sourcing to end-product formulation—are being adopted to ensure quality control and reduce dependency on third-party suppliers. As the industry evolves, collaboration between academia, regulatory bodies, and private enterprises will play a critical role in shaping market dynamics and ensuring sustainable growth.

TOP PLAYERS IN THE MARKET

Chr. Hansen A/S

One of the leading companies in the global probiotic ingredients market is Chr. Hansen A/S, a Danish bioscience firm renowned for its expertise in microbial solutions. The company has been at the forefront of developing high-quality, scientifically backed probiotic strains used across food, dietary supplements, and animal nutrition. Chr. Hansen's commitment to research and sustainability has made it a trusted partner for major dairy producers and pharmaceutical firms worldwide.

Dupont Nutrition & Biosciences

Another key player is Dupont Nutrition & Biosciences, now part of IFF, which has significantly shaped the probiotics landscape through innovation and strategic acquisitions. Dupont focuses on delivering clinically validated probiotic strains that support digestive and immune health. Its extensive portfolio serves a wide range of industries, from infant nutrition to functional foods, reinforcing its strong global presence.

Lallemand Inc.

Lallemand Inc., a Canadian company specializing in yeast and bacteria-based products, is also a major contributor to the probiotic ingredients market. Lallemand offers diverse probiotic formulations tailored for human health, animal feed, and industrial applications. With a strong emphasis on natural fermentation processes and microbiology, Lallemand continues to expand its influence in both developed and emerging markets.

TOP STRATEGIES USED BY KEY MARKET PLAYERS

A primary strategy adopted by leading players in the probiotic ingredients market is product differentiation through scientific validation . Companies are investing heavily in clinical research to demonstrate the efficacy of specific strains, thereby enhancing consumer trust and meeting regulatory standards for health claims.

Another crucial approach is strategic collaborations with academic institutions, healthcare professionals, and food manufacturers. These partnerships help in expanding product applications, gaining insights into evolving consumer needs, and integrating probiotics into mainstream nutritional and medical products.

Lastly, market expansion into emerging regions and diversification across application areas is a key focus for growth. Major firms are adapting their probiotic offerings for use in infant formulas, plant-based foods, personal care, and veterinary sectors, while strengthening distribution networks in Asia-Pacific, Latin America, and Africa to capture new customer segments.

RECENT HAPPENINGS IN THE MARKET

• In January 2023, Chr. Hansen introduced a new line of probiotic cultures specifically designed for plant-based dairy alternatives, addressing the growing demand for vegan-friendly functional foods and beverages.
• In May 2023, Dupont expanded its probiotic research facility in the United States to accelerate the development of next-generation strains targeting gut-brain axis health and metabolic wellness.
• In October 2023, Lallemand launched a probiotic-based poultry feed additive aimed at improving gut health and reducing antibiotic use in livestock farming, aligning with global trends toward sustainable agriculture.
• In February 2024, a leading Japanese probiotic manufacturer partnered with a European biotech firm to co-develop advanced delivery systems that enhance the survival rate of live cultures during digestion.
• In August 2024, an Indian nutraceutical startup secured funding to scale up production of indigenous probiotic strains tailored for the South Asian population, focusing on region-specific gut health benefits.
• In April 2024, DynaTouch, a kiosk solutions provider, acquired KioWare, a kiosk management software company. This acquisition is anticipated to allow DynaTouch to offer more comprehensive kiosk solutions and strengthen their market presence.

MARKET SEGMENTATION

This research report on the global probiotic ingredients market has been segmented and sub-segmented based on form, ingredient, application, end user, and region.

By Form

• Liquid
• Dry/powder

By Ingredient

• Yeast
• Spore Formers
• Bacteria
  • Streptococcus
  • Bifidobacterium
  • Lactobacilli
  • Other Genus

By Application:

• Dietary Supplements
  • Soft Gels
  • Powders
  • Tablets
  • Capsules
  • Chewable and Gummies
  • Others
• Functional Food and Beverages
  • Dairy Products
    • Cheese
    • Yogurt
    • Others
  • Non-dairy Products
    • Cereals
    • Bakery
    • Functional Beverages
    • Others
• Animal Nutrition
• Others

By End User

• Human Probiotics
• Animal Probiotics

By Region

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa